Outset Medical, Inc.
OM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $113,689 | $130,376 | $115,375 | $102,602 |
| % Growth | -12.8% | 13% | 12.4% | – |
| Cost of Goods Sold | $75,125 | $101,376 | $97,542 | $94,994 |
| Gross Profit | $38,564 | $29,000 | $17,833 | $7,608 |
| % Margin | 33.9% | 22.2% | 15.5% | 7.4% |
| R&D Expenses | $38,397 | $57,307 | $48,855 | $36,741 |
| G&A Expenses | $43,498 | $45,231 | $40,515 | $36,316 |
| SG&A Expenses | $113,542 | $141,463 | $129,997 | $101,386 |
| Sales & Mktg Exp. | $70,044 | $96,232 | $89,482 | $65,070 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $151,939 | $198,770 | $178,852 | $138,127 |
| Operating Income | -$113,375 | -$169,770 | -$161,019 | -$130,519 |
| % Margin | -99.7% | -130.2% | -139.6% | -127.2% |
| Other Income/Exp. Net | -$14,110 | -$2,504 | -$1,642 | -$1,217 |
| Pre-Tax Income | -$127,485 | -$172,274 | -$162,661 | -$131,736 |
| Tax Expense | $491 | $523 | $295 | $199 |
| Net Income | -$127,976 | -$172,797 | -$162,956 | -$131,935 |
| % Margin | -112.6% | -132.5% | -141.2% | -128.6% |
| EPS | -2.46 | -3.48 | -3.38 | -2.89 |
| % Growth | 29.3% | -3% | -17% | – |
| EPS Diluted | -2.46 | -3.48 | -3.38 | -2.89 |
| Weighted Avg Shares Out | 3,463 | 3,306 | 3,211 | 3,039 |
| Weighted Avg Shares Out Dil | 3,463 | 3,306 | 3,211 | 3,039 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,761 | $10,171 | $3,291 | $498 |
| Interest Expense | $23,871 | $12,675 | $3,566 | $1,715 |
| Depreciation & Amortization | $5,728 | $5,810 | $6,283 | $6,184 |
| EBITDA | -$97,886 | -$153,789 | -$152,812 | -$124,859 |
| % Margin | -86.1% | -118% | -132.4% | -121.7% |